DNA binding activity of serum from patients with systemic lupus erythematosus. 1979

J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy

The reaction conditions essential for reproducible use of the cellulose ester membrane filter assay for anti-DNA antibody levels in patients with systemic lupus erythematosus are described. A dependence of DNA-binding capacity on serum concentration was observed in the assay, requiring that serum concentrations be comparable in determinations of DNA-binding activity of different sera and when comparing different published studies. The DNA-binding capacity of serum from lupus patients was found to be significantly different from that of healthy controls. However, the binding capacities were not significantly different between lupus patients with and without nephritis. The relative avidity of the anti-DNA antibodies were estimated from plots of 1/DNA bound vs 1/DNA free and these data indicate that the avidities of the antibodies from the two groups of lupus patients are not significantly different. This observation suggests that the tightness of binding between the DNA and the serum anti-DNA antibodies cannot be used to predict immune complex-induced nephritis in lupus patients.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009393 Nephritis Inflammation of any part of the KIDNEY. Nephritides
D001810 Blood Volume Volume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME. Blood Volumes,Volume, Blood,Volumes, Blood
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody

Related Publications

J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
September 1969, The New England journal of medicine,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
March 1977, The American journal of medicine,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
December 1977, The Journal of clinical investigation,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
December 1975, The Journal of clinical investigation,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
January 1981, Clinical immunology and immunopathology,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
June 2007, Autoimmunity,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
January 1975, Acta dermato-venereologica,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
October 1978, Clinical immunology and immunopathology,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
May 2002, Journal of the American Society of Nephrology : JASN,
J F Halsey, and W A Woolery, and S Oleinick, and M B Kahaleh, and E C Leroy
January 1985, Cleveland Clinic quarterly,
Copied contents to your clipboard!